Benutzerbeiträge
- 13:09, 23. Jan. 2018 (Unterschied | Versionen) . . (+3.818 Bytes) . . N F idea to filing an IND, to proof of concept to (Die Seite wurde neu angelegt: „Certainly FDA originally wanted to [https://dx.doi.org/10.1186/s12889-015-2195-2 title= s12889-015-2195-2] apply the identical rules, plus the exact same kinds…“)
- 10:35, 23. Jan. 2018 (Unterschied | Versionen) . . (+3.925 Bytes) . . N Rm and its partners disagree about commercialization techniques or one of the most (Die Seite wurde neu angelegt: „doi:10.1186/s12891-016-0883-4. 6. Horkey J, King P. regulations tailored to other, incredibly unique, varieties of drugs. These incorporate angel and venture f…“) (aktuell)
- 08:48, 23. Jan. 2018 (Unterschied | Versionen) . . (+3.743 Bytes) . . N Ecause in the event you...make procedure adjustments...you would like to make certain (Die Seite wurde neu angelegt: „Most cell therapies is not going to stay viable at ambient temperature more than an extended period of time and can, as a result, demand far more complicated d…“) (aktuell)